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Background
FMF is a genetic autoinflammatory disease, characterized
by attacks of fever and painful serositis. Behcet's disease
(BD) is an inflammatory disorder associated with vasculi-
tis. Clinical manifestations of both diseases can mimic
each other and the coexistence of both diseases in the
same patient has been reported.
Objective
We observed 2 siblings (11 and 10 year-old) of Egyptian
ancestry, with a single MEFV gene mutation and clinical
symptoms of FMF and BD.
Their medical history of recurrent fever attacks started at
the age of 14 and 6 months respectively. Fever was accom-
panied by cervical adenopathy, severe exudative pharyngi-
tis, oral aphtosis, abdominal pain and diarrhoea,
sometimes with bloody stools. At the age of 10 and 9
years, screening for autoinflammatory disorders was per-
formed revealing a single mutated FMF gene (E148Q).
Since they fulfilled Tel Hashomer criteria, colchicine was
started.
Despite colchicines, both still presented shorter fever
attacks, recurrent abdominal pain with diarrhoea, oral
and genital aphtosis, mialgia and asthenia. Blood tests
and abdominal ultrasound were normal. An ophthalmic
evaluation showed panuveitis in both.
Recurrence of oral and genital ulcers, abdominal pain and
uveitis strongly suggested the diagnosis of BD even
though HLA B51 was not detected.
Conclusion
Diagnosis of FMF and BD is clinical. Our patients fulfilled
Tel Hashomer criteria for FMF and international diagnos-
tic criteria of BD. The increase of colchicine induced a sus-
tained clinical improvement. Physicians have to be aware
of the possible association of both conditions.
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